Cargando…
Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer
BACKGROUND: Gastric cancer (GC) is highly biologically and genetically heterogeneous disease with poor prognosis. Increasing evidence indicates that biomarkers can serve as prediction and clinical intervention. Therefore, it is vital to identify core molecules and pathways participating in the devel...
Autores principales: | Wang, Shuoshan, Yang, Xiansheng, Liu, Chang, Hu, Jinlun, Yan, Mei, Ding, Chan, Fu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553055/ https://www.ncbi.nlm.nih.gov/pubmed/37800754 http://dx.doi.org/10.1097/MD.0000000000035111 |
Ejemplares similares
-
Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021) -
Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
por: Dong, Shu, et al.
Publicado: (2017) -
Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients
por: Zhang, Xin, et al.
Publicado: (2018) -
Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer
por: Li, Tao, et al.
Publicado: (2017) -
Relationship between the incidence of non-hepatic hyperammonemia and the prognosis of patients in the intensive care unit
por: Yao, Zhi-Peng, et al.
Publicado: (2020)